about
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand.Differential diagnosis of trampoline fracture from osteomyelitis by bone scan with pinhole collimator.Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma.99mTc-NTP 15-5 Imaging for Cartilage Involvement in Experimental Rheumatoid Arthritis: Comparison with Routinely Used Molecular Imaging Methods and Sensitivity to Chronic Nonsteroidal Antiinflammatory Drug Treatment.Radium 223 dichloride for prostate cancer treatmentEarly detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.Case of thyroid involvement by multiple myeloma.Evidence of a clinical response at one yr after reduced-intensity allogeneic hematopoietic stem cell transplantation in heavily pretreated adolescents with aggressive refractory Hodgkin's lymphoma.Low-dose dual-isotope procedure planed for myocardial perfusion CZT-SPECT and assessed through a head-to-head comparison with a conventional single-isotope protocol.Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.Incidental scintigraphic finding of ovarian teratoma containing normal thyroid tissue on post-radioactive iodine therapy for papillary thyroid cancer.Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.18F-Fluorodeoxyglucose positron emission tomography in Whipple's diseaseIn vivo experimental imaging of osteochondral defects and their healing using 99mTc-NTP 15-5 radiotracerSentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentationDoes 99mTc-sestamibi uptake discriminate breast tumors?Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patientsClinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patientsTwo more cases of evaluation of POEMS syndrome using 18-FDG PET/CT[Update of the recommendations of good clinical practice for the use of PET in oncology]Radiation dosimetry of [131 I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatmentStimulated thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancerAge, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patientsAssessment of four different cardiac softwares for evaluation of LVEF with CZT-SPECT vs CMR in 48 patients with recent STEMI
P50
Q38924577-3FC38781-6B25-40B6-A686-CF0791926358Q40183123-87DE2482-7DBD-4525-ABDF-97048D862BD6Q40234305-E75B3F68-5D78-4244-AD22-200A5CAD7E81Q40528778-E494D2D8-C72C-4C1F-9EF9-8876889CBB43Q41117095-9B22D7C5-E24C-472C-901A-E55DC571CCD9Q41354888-418AC0AF-1890-4211-8341-F4A24D744494Q43480586-7A74F101-1B3B-4FFC-9A4D-10629BC875D9Q43498641-89DFA343-2547-4DD2-B216-5697FA26AB38Q44743124-1A8A6E1F-DACE-40CE-9942-DB467838964AQ45985799-793B54E3-A533-46A5-9DEE-10DD8A6CA602Q48603894-B573E2A0-741A-4157-98A7-3BC4E2F249FEQ51177755-75793F41-6D88-4686-AA26-A4A827CE224BQ53115560-6C287319-B0C7-4E01-9B72-9D9E5D1F2C93Q53536949-95912A0F-A25D-4E03-96E5-98BE7BF9499CQ56623365-7C0DC3F1-F11F-4AB8-9A63-13064DE3B1A7Q61868356-3CF5A7F1-368C-4C4A-86FF-EE924627D0C4Q80800181-0D0CA1A0-6D51-4AAD-A3E9-E1D13E0AA793Q81061982-C50CB0B2-F96E-49B7-87FC-D7C8AA3DCED2Q82898371-6D9046AC-46E9-4B76-A19F-36BE14A296C6Q83756422-1C5A1606-3249-4771-B8B3-86533C81CB2CQ84325491-12ED4E2B-A67F-4F85-B5BC-7C084A6B3557Q91227104-293C143C-D3A4-4535-80DD-5180631F672BQ91281541-8A9E5073-54E7-49FF-AEAF-DAB31F82B7CFQ91748945-F0BDF8AB-92ED-43B6-9106-7DC40AAB3764Q92455021-A6182605-6497-4F5E-ACA4-87E5BA079EF5Q92697960-4967044A-3A63-49E7-82E9-6DB722C7C565Q93062955-3081DFF6-5A61-4969-8483-A00080E76E37
P50
description
investigador
@es
researcher
@en
name
Florent Cachin
@en
Florent Cachin
@nl
type
label
Florent Cachin
@en
Florent Cachin
@nl
prefLabel
Florent Cachin
@en
Florent Cachin
@nl
P31
P496
0000-0003-2171-1496